Daiichi Sankyo Seeks Approval For Flu Drug, Plans Second Use
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo has applied to be the second maker of a flu drug in Japan. The company's version is an inhalant, and if approved could be on the market this fall